Cartalax is a scientifically-proven supplement that can help to promote healthy joints and reduce joint pain and inflammation. It is formulated with a blend of natural ingredients that work together to support joint health and improve joint function. It also includes ingredients that have been shown to reduce inflammation, such as MSM and Boswellia serrata extract.
Research in fibroblasts and the skin shows that Cartalax increases cell proliferation, tissue regeneration, and extracellular matrix remodeling, particularly in older animals, while decreasing apoptosis. This effect appears to be mediated through the cells primarily responsible for deposition of extracellular matrix in tendon, skin, and cartilage—fibroblasts.
In addition, Cartalax stimulates the expression of a number of genes known to play an important role in aging, including IGF1, FOXO1, TERT, TNKS2, and NF-kB. It also enhances the expression of SIRT-6, which is a key regulator of aging.
Other studies in renal (kidney) cells show that Cartalax decreases p53 expression, which is commonly associated with cellular aging. It also inhibits MMP-9 synthesis, which is known to increase during the aging process. It also increases expression of Ki-67 and CD98hc, which are decreased during aging.
It is not known if Cartalax can specifically benefit cartilage. However, a lot of research has been done on fibroblasts and Cartalax, which makes it possible that the ingredients in Cartalax can benefit the function of cartilage. For example, glucosamine and chondroitin are both known to be essential components of healthy cartilage. MSM is also a naturally-occurring substance found in cartilage that has been shown to reduce inflammation.